Artificial Intelligence and Its Impact on Healthcare Financing in China – A Legal Analysis

Authors

Keywords:

healthcare, financing, artificial intelligence, China, pharmaceuticals

Abstract

The Chinese national health system has undergone massive changes in the last several decades with financing becoming a cornerstone of the development of the Chinese healthcare environment. Several private companies have entered the sector private healthcare with consumers being more health conscious and aware. Furthermore, the Chinese government have transformed the healthcare insurance system to expand the coverage of the population and initiate more market-oriented reforms. AI has been another major game changer in the healthcare sector and the financial industry with driving both patient evaluation as well as enhancing finance related investments. Within China, AI has several important functions via its integration in the regulation process and becoming a vital part of the regulatory process. AI may provide some vital opportunities for healthcare financing, but this requires a more solid framework to support broader utilization of AI for the financing of the sector. The article provides a solid legal analysis of artificial intelligence regulations and its applications to healthcare within China. It outlines the advances in cybersecurity and artificial intelligence regulations in China and the changing regulatory ecosystem, demonstrating the challenges that may be faced by the Chinese healthcare system.

Downloads

Download data is not yet available.

References

Apell, P., & Eriksson, H.: Artificial intelligence (AI) healthcare technology innovations: the current state and challenges from a life science industry perspective. Technology Analysis & Strategic Management, vol. 35, no. 2, 2023.

Baird, K.: High out-of-pocket medical spending among the poor and elderly in nine developed countries. Health Services Research, vol. 51, no. 4, 2016.

Cao, Y., & Zhai, J.: A survey of AI in finance. Journal of Chinese Economic and Business Studies, 2022.

Cheng, J., & Zeng, J.: Shaping AI’s future? China in global AI governance. Journal of Contemporary China, vol. 32, no. 143, 2023.

Dixon, R.: A principled governance for emerging AI regimes: lessons from China, the European Union, and the United States. AI and Ethics, vol. 3, no. 3, 2023.

Feng, J., Hong, G., Qian, W., Hu, R., & Shi, G.: Aging in China: an international and domestic comparative study. Sustainability, vol. 12, no. 12, 2020.

Guo, Y., Chen, W., Zhao, J., & Yang, G. Z.: Medical robotics: opportunities in China. Annual Review of Control, Robotics, and Autonomous Systems, 2022.

Hine, E.: Governing Silicon Valley and Shenzhen: Assessing a New Era of Artificial Intelligence Governance in the US and China. 2023 AAAI/ACM Conference on AI, Ethics, and Society , 2023.

Hougaard, J. L.: Østerdal, L. P., & Yu, Y.: The Chinese healthcare system: structure, problems and challenges. Applied health economics and health policy, vol. 9, 2011.

Knox, J.: Artificial intelligence and education in China. Learning, Media and Technology, vol. 45, no 3, 2020.

Lee, J. Y.: Artificial Intelligence Cases in China: Feilin v. Baidu and Tencent Shenzhen v. Shanghai Yingxin. China and WTO Review, vol. 7, no. 1, 2021.

Lemonnier, M.: Interpretation of the tax law in France. Financial Law Review, vol. 7 (3), 2017.

Li, X. W., & Miao, H. Z.: How to Incorporate Autonomous Vehicles into the Carbon Neutrality Framework of China: Legal and Policy Perspectives. Sustainability, vol. 15, no. 7, 2023.

Lin, T.: Artificial intelligence, finance, and the law. Fordham L. Rev., vol. 88, 2019.

Ma, C., Zhang, Y., Li, Y., Wang, Y., Jiang, Y., Wang, X., Ma, S. Healthcare, insurance, and medical expenditure of the floating population in Beijing, China. Frontiers in Public Health vol. 375, 2020.

Mao, W., Yip, C. M., Chen, W.: Complications of diabetes in China: health system and economic implications. BMC public health, vol. 19, no. 1, 2019.

Qian, J.: Reallocating authority in the Chinese health system: an institutional perspective. The Chinese National Health Care Reform, 2017.

Roberts, H., Cowls, J., Hine, E., Morley, J., Wang, V., Taddeo, M., & Floridi, L.: Governing artificial intelligence in China and the European Union: Comparing aims and promoting ethical outcomes. The Information Society, 2023.

Saraswat, D., Bhattacharya, P., Verma, A., Prasad, V. K., Tanwar, S., Sharma, G., & Sharma, R.: Explainable AI for healthcare 5.0: opportunities and challenges. IEEE Access, 2022.

Tang, N., & Thomson, L. E.: Workplace violence in Chinese hospitals: the effects of healthcare disturbance on the psychological well-being of Chinese healthcare workers. International journal of environmental research and public health, vol. 16, no. 19, 2019.

Wang, L., Wang, Z., Ma, Q., Fang, G., Yang, J.: The development and reform of public health in China from 1949 to 2019. Globalization and health, vol. 15, no. 1, 2019.

Wu, F., Lu, C., Zhu, M., Chen, H., Zhu, J., Yu, K., Pan, Y.: Towards a new generation of artificial intelligence in China. Nature Machine Intelligence, 2020.

Yi, B.: An overview of the Chinese healthcare system. Hepatobiliary Surgery and Nutrition, vol. 10, no. 1, 2021.

Zhang, S., Chen, Q., & Zhang, B.: Understanding healthcare utilization in China through the Andersen behavioral model: review of evidence from the China health and nutrition survey. Risk management and healthcare policy, 2019.

Zielińska-Lont, K.: Sustainable finance initiatives and their impact on financial stability. Financial Law Review, vol. 20, no. 4, 2020.

Downloads

Published

01.06.2024

How to Cite

Katterbauer, K., & Cleenewerck, L. (2024). Artificial Intelligence and Its Impact on Healthcare Financing in China – A Legal Analysis. Financial Law Review, (33(1), 62–81. Retrieved from https://czasopisma.bg.ug.edu.pl/index.php/flr/article/view/10759

Issue

Section

Articles